Cargando…
Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study
BACKGROUND: The benefit of adjuvant chemotherapy (ACT) remains unknown for patients with stage I lung adenocarcinoma (ADC) with spread through air spaces (STAS). This study investigated the effect of adjuvant chemotherapy in stage I ADC/STAS-positive patients. METHODS: A total of 3346 patients with...
Autores principales: | Chen, Donglai, Wang, Xiaofan, Zhang, Fuquan, Han, Ruoshuang, Ding, Qifeng, Xu, Xuejun, Shu, Jian, Ye, Fei, Shi, Li, Mao, Yiming, Chen, Yongbing, Chen, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739212/ https://www.ncbi.nlm.nih.gov/pubmed/33403018 http://dx.doi.org/10.1177/1758835920978147 |
Ejemplares similares
-
Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma
por: Qiu, Xie, et al.
Publicado: (2019) -
Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Xiaofan, et al.
Publicado: (2021) -
Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma
por: Xu, Xuejun, et al.
Publicado: (2023) -
Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
por: Chen, Donglai, et al.
Publicado: (2021) -
Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score
por: Chen, Donglai, et al.
Publicado: (2019)